Dannielle Appelhans Rubius Therapeutics, Inc. (RUBY) insider trading activity

Dannielle Appelhans is CEO and President of Rubius Therapeutics, Inc.. Currently has a direct ownership of 0 shares of RUBY, which is worth approximately $0. The most recent transaction as insider was on Feb 24, 2023, when has been sold 10,385 shares (Common Stock) at a price of $0.13 per share, resulting in proceeds of $1,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Dannielle Appelhans Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 24 2023	SELL Open market or private sale	$1,350 $0.13 p/Share	10,385 Reduced 100.0%	0 Common Stock
Feb 01 2023	SELL Open market or private sale	$969 $0.25 p/Share	3,878 Reduced 27.19%	10,385 Common Stock
Jan 31 2023	BUY Exercise of conversion of derivative security	-	7,500 Added 34.46%	14,263 Common Stock
Aug 10 2022	SELL Open market or private sale	$4,590 $0.8 p/Share	5,737 Reduced 45.9%	6,763 Common Stock
Aug 09 2022	BUY Exercise of conversion of derivative security	-	12,500 Added 50.0%	12,500 Common Stock

Also insider at

GBIO

Generation Bio Co. Healthcare